The functional responses of endothelial cells are dependent on signaling from peptide growth factors and the cellular adhesion receptors, integrins. These include cell adhesion, migration, and proliferation, which, in turn, are essential for more complex processes such as formation of the endothelial tube network during angiogenesis. This study identifies the molecular requirements for the cross-activation between ␤ 3 integrin and tyrosine kinase receptor 2 for vascular endothelial growth factor (VEGF) receptor (VEGFR-2) on endothelium. The relationship between VEGFR-2 and ␤ 3 integrin appears to be synergistic, because VEGFR-2 activation induces ␤ 3 integrin tyrosine phosphorylation, which, in turn, is crucial for VEGF-induced tyrosine phosphorylation of VEGFR-2. We demonstrate here that adhesionand growth factor-induced ␤ 3 integrin tyrosine phosphorylation are directly mediated by c-Src. VEGF-stimulated recruitment and activation of c-Src and subsequent ␤ 3 integrin tyrosine phosphorylation are critical for interaction between VEGFR-2 and ␤ 3 integrin. Moreover, c-Src mediates growth factor-induced ␤ 3 integrin activation, ligand binding, ␤ 3 integrin-dependent cell adhesion, directional migration of endothelial cells, and initiation of angiogenic programming in endothelial cells. Thus, the present study determines the molecular mechanisms and consequences of the synergism between 2 cell surface receptor systems, growth factor receptor and integrins, and opens new avenues for the development of pro-and antiangiogenic strategies. (Circ Res. 2007;101:570-580.) Key Words: angiogenesis Ⅲ endothelial cell Ⅲ ␤ 3 integrin signaling Ⅲ vascular endothelial growth factor receptor Ⅲ extracellular matrix proteins Original
A ngiogenesis, the process of new blood vessel formation from preexisting vasculature, plays critical roles in tissue regeneration, postischemic tissue repair on myocardial infarction and stroke, and in the pathogenesis of cancer, rheumatoid arthritis, and diabetic microvascular disease. 1 Angiogenesis is triggered by angiogenic growth factors and their receptors in coordination with extracellular matrix (ECM) receptors known as integrins. 2 On integrin engagement, ECM triggers activation of numerous intracellular signaling pathways essential for endothelial cell (EC) survival, proliferation, migration, morphogenesis, and organization of ECs into blood vessels. 3 There are several manifestations of a tightly collaborative relationship between integrins and receptors for growth factors. 4, 5 On ECs, engagement of ␣ v ␤ 3 integrin promotes phosphorylation and activation of vascular endothelial growth factor (VEGF) receptor (VEGFR)-2, thereby augmenting the mitogenic activity of VEGFs. 6 Among several integrins on ECs, ␣ v ␤ 3 is the most abundant and influential receptor regulating angiogenesis. 7 The upregulation of ␣ v ␤ 3 during angiogenesis suggests that this integrin might play a crucial role during this process. Indeed, antagonists of ␣ v ␤ 3 , including blocking monoclonal antibody (LM609) and RGD cyclic peptides, were shown to be efficient inhibitors of neovascularization in several experimental animal models. 8 -10 Results of preclinical models have justified ongoing clinical trials of humanized monoclonal antibodies and cyclic peptides, which specifically target ␣ v ␤ 3 . 11 That ␣ v ␤ 3 regulates tumor-induced angiogenesis is clear, although its precise role remains disputed, [12] [13] [14] [15] indicating the need for conclusive mechanistic studies.
At the structural level, the function of this integrin is regulated by its cytoplasmic domain. Conserved regions present within the ␤ 3 integrin (␤ 3 ) cytoplasmic domain include NPXY and NXXY motifs, 16 the tyrosine residues of which can be phosphorylated to regulate interactions with signaling proteins containing SH3 and PTB domains. 17 Phosphorylation of ␤ 3 modulates several intracellular events, including VAV-1/Rho GTPase activation, actin cytoskeleton reorganization and regulation of the phosphatidylinositol 3-kinase/AKT pathway, which is involved in the regulation of basic cellular functions such as cell spreading and survival. 18 Thus, phosphorylation of ␤ 3 cytoplasmic domain is critical for ␣ v ␤ 3 integrin-dependent functions because it regulates ␣ v ␤ 3 affinity, avidity, and ligand-binding strength. 19 -21 Although the responses regulated by ␤ 3 phosphorylation are numerous and functionally important, this phenomenon has not been thoroughly studied, leaving critical gaps in our understanding of the molecular mechanisms underlying the process of receptor cross-activation.
Materials and Methods
Reagents and plasmids used in this study, cell culture and transfection, isolation of primary mouse ECs, cell adhesion assays, cell migration assays, tube formation assays, time-lapse video microscopy, in vitro kinase assays, fibrinogen and WOW-1-binding assays, and immunoprecipitation and immunoblotting methods are described in the online data supplement at http://circres.ahajournals.org.
Statistical Analysis
Values were expressed as meanϮSD. Probability values were based on the paired t test. Results were considered statistically significant with a probability value less than 0.05.
Results

␤ 3 Integrin Tyrosine Phosphorylation Is Required for Maximum Tyrosine Phosphorylation of VEGFR-2
As a first step to examine the relationship between integrin ligation, ␤ 3 phosphorylation and VEGFR-2 activation, we monitored phosphorylation of ␤ 3 at Tyr747 and Tyr759 in ECs plated on the ␣ v ␤ 3 ligand vitronectin, the ␣ 2 ␤ 1 ligand collagen, or the ␣ 6 ␤ 1 /␣ 6 ␤ 4 ligand laminin. As a control, the ECs were maintained in suspension in the presence or absence of VEGF stimulation. As shown in Figure 1A , vitronectin, but not laminin or collagen, was able to induce ␤ 3 phosphorylation, which was augmented on VEGF treatment. At the same time, phosphorylation of ␤ 3 was minimal in cells in suspension or plated on laminin or collagen despite stimulation with VEGF ( Figure 1A ). Human umbilical vein ECs (HUVECs) also exhibited differential adhesion to various integrin ligands ( Figure IIA and IIB in the online data supplement). Analysis of VEGFR-2 tyrosine phosphorylation in the same set of samples revealed that basal level VEGFR-2 activation can be triggered by ␣ v ␤ 3 ligation induced by vitronectin but does not occur in cells plated on collagen or laminin. Parallel analysis of ␤ 1 phosphorylation status showed no significant difference with VEGF stimulation (supplemental Figure IA) . Thus, whereas VEGF stimulation promotes phosphorylation of ␣ v ␤ 3 , ligation of ␣ v ␤ 3 also stimulates VEGFR-2 phosphorylation, and activation, demonstrating a mutual relationship between VEGFR-2 and ␣ v ␤ 3 .
␤ 3 Integrin Tyrosine Phosphorylation Is Complementary to VEGF-Induced Tyrosine Phosphorylation of VEGFR-2
␣ v ␤ 3 is expressed on proliferating ECs during angiogenesis and vascular remodeling and the blockade of ␣ v ␤ 3 suppresses angiogenesis in several in vivo models. [13] [14] [15] [16] Therefore, we assessed whether the blockade of ␣ v ␤ 3 affected tyrosine phosphorylation of the ␤ 3 subunit. Accordingly, HUVECs grown on gelatin-coated plates were incubated with anti-␣ v , anti-␤ 3 , anti-␤ 1 , and anti-␤ 5 blocking antibodies and induced with VEGF for 5 minutes at 37°C. Cell lysates were analyzed for phosphorylation of ␤ 3 at Tyr747 and Tyr759. Figure 1B shows that both anti-␣ v and anti-␤ 3 blocking antibodies inhibited VEGF-induced phosphorylation of ␤ 3 at both residues. Simultaneously, control IgG, anti-␤ 1 , or anti-␤ 5 block-ing antibodies had no substantial effects on VEGF-induced phosphorylation of ␤ 3 .
To further examine the consequences of integrin blocking antibodies, cell lysates were analyzed for tyrosine phosphorylation of VEGFR-2. Results indicated that only anti-␣ v and anti-␤ 3 function blocking antibodies suppressed VEGFinduced phosphorylation of VEGFR-2, whereas anti-␤ 1 or anti-␤ 5 blocking antibodies had no effect on VEGF-induced activation of VEGFR-2 ( Figure 1C ). Furthermore, treatment of HUVECs grown on gelatin-coated plates with VEGFR-2 inhibitor significantly reduced VEGF-induced ␤ 3 phosphorylation ( Figure 1D ). Taken together, these results demonstrate the cross-activation between the 2 receptors: ␣ v ␤ 3 ligation controls not only tyrosine phosphorylation of ␤ 3 but also of VEGFR-2, and VEGF stimulation promotes not only VEGFR-2 but also ␤ 3 tyrosine phosphorylation.
As VEGFR-2 activation and signaling seemed to be tightly associated with integrins, we extended our examination to the interaction of VEGFR-2 with other EC integrins. Results indicate that VEGF induced interaction of VEGFR-2 with ␤ 3 ( Figure 1E ). A small fraction of VEGFR-2 was also found to interact with ␤ 1 but not with ␤ 5 (supplemental Figure IB) . Thus, of the 3 classes of integrins expressed on ECs, only ␣ v ␤ 3 forms a complex with VEGFR-2 after VEGF treatment.
VEGF Differentially Induces Interaction of Src Family Tyrosine Kinases With ␤ 3 Integrin in Endothelial Cells
The presence of Src family tyrosine kinases (SFKs) is critical for the phosphorylation of several intracellular signaling molecules following integrin-mediated cell adhesion and cell spreading. 22 Therefore, we sought to analyze the degree and range of SFKs interactions with ␤ 3 and VEGFR-2 on VEGF stimulation. In resting ECs, only small amounts of c-Src associated with both VEGFR-2 and ␤ 3 . VEGF stimulation dramatically enhanced interaction of c-Src with VEGFR-2 and ␤ 3 . No basal level or VEGF-induced interaction was found between Fyn and ␤ 3 or VEGFR-2. A moderate amount of Yes was always associated with ␤ 3 and VEGFR-2, even after VEGF induction (Figure 2A and 2B). Therefore, we conclude that c-Src is the major tyrosine kinase associated with ␤ 3 following stimulation of cells with growth factor, possibly the kinase responsible for phosphorylation of ␤ 3 cytoplasmic tyrosines. To confirm these observations, kinetic analyses of ␤ 3 and c-Src tyrosine phosphorylation were performed. VEGF induced phosphorylation of ␤ 3 at 2.5 minutes, and it remained phosphorylated up to 30 minutes. Maximal ␤ 3 phosphorylation was observed between 5 and 15 minutes. VEGF also induced a similar activation phosphorylation of c-Src in ECs ( Figure 2C ), leading us to consider that activated c-Src might be responsible for ␤ 3 phosphorylation, which is crucial for activation of ␤ 3 integrin-dependent cellular signaling and EC functions.
Adhesion and Growth Factor-Induced ␤ 3 Integrin Tyrosine Phosphorylation Is Mediated Through c-Src
The cytoplasmic tyrosine motifs of ␤ 3 integrin known to regulate FAK phosphorylation, integrin-dependent actin cy- Figure 1 . Phosphorylation of ␤ 3 integrin cytoplasmic tyrosine is crucial for VEGFR-2 activation. Cells were induced with 20 ng/mL VEGF for 5 minutes. A, HUVECs were either kept in suspension or plated on vitronectin, laminin, or collagen and allowed to adhere and spread for 30 minutes and were then induced with VEGF. Cell lysates were analyzed for phosphorylation of ␤ 3 cytoplasmic tyrosines and phospho (P)-VEGFR-2 using specific antibodies. B and C, Effect of integrin-blocking antibodies on ␤ 3 and VEGFR-2 tyrosine phosphorylation. HUVECs were incubated with specific or control antibody for 1 hour and then induced with VEGF. Lysates were analyzed for phosphorylation of ␤ 3 (B, top images) and VEGFR-2 (C, top image) using specific antibody. D, Serum-starved HUVECs were treated with 400 and 800 nmol/L VEGFR-2 inhibitor SU1498 (lanes 3 and 4) ad then induced with VEGF. Lysates were analyzed for ␤ 3 tyrosine phosphorylation using specific antibodies. E, ␤ 3 interacts with VEGFR-2 following VEGF stimulation. HUVECs were induced with VEGF; lysates were immunoprecipitated with anti-VEGFR-2 antibody and then separately immunoblotted with anti-␤ 5 , anti-␤ 1 , and anti-␤ 3 antibodies. HUVEC whole-cell lysate served as control (lane 1). toskeletal reorganization, the ability of integrins to localize to focal contacts, and cellular adhesion and spreading. 16 Therefore, we examined the role of c-Src in adhesion-and growth factor-induced phosphorylation of ␤ 3 cytoplasmic tyrosine motifs. Accordingly, HUVECs were either kept in suspension ( Figure 3A , lane 1) or plated on vitronectin (lane 2) and then treated with VEGF (lane 3) or SU6656, a specific c-Src inhibitor (lane 4). Cell lysates were analyzed for ␤ 3 integrin phosphorylation. As anticipated, in comparison with HUVECs kept in suspension, cells plated on vitronectin showed high levels of ␤ 3 phosphorylation at Tyr747 and Tyr759, which were further augmented by VEGF. Treatment of adherent ECs with SU6656 significantly reduced ␤ 3 phosphorylation. Furthermore, SU6656 also reduced basal adhesion-induced ␤ 3 tyrosine phosphorylation in these cells (supplemental Figure VIIB) . As an independent approach, HUVECs were transfected with wild-type (WT), dominant negative (DN), and catalytically active (CA) forms of Src. Cells transfected with DN-Src showed severe impairment in adhesion as well as VEGF-induced ␤ 3 phosphorylation (lanes 5 and 6). In contrast, expression of CA-Src dramatically enhanced adhesion as well as VEGF-induced phosphorylation of ␤ 3 on both Tyr747 and Tyr759 (lanes 9 and 10). Transfection of HUVECs with WT c-Src did not significantly alter adhesion or VEGF-induced ␤ 3 phosphorylation (lanes 7 and 8).
To further substantiate the specific role of c-Src in ␤ 3 phosphorylation, we used cellular systems in which c-Src expression is highly regulated. 22 As shown in Figure 3B , no ␤ 3 phosphorylation was observed in any of these cell types when either plated on uncoated plastic surfaces or kept in suspension (lanes 2 and 3). Attachment to vitronectin stimulated high levels of ␤ 3 phosphorylation in Src ϩϩ and SYF ϩ c-Src cells but not in SYF cells (lane 4). Cells plated on laminin or collagen showed very low ␤ 3 phosphorylation (lanes 5 and 6). On growth factor stimulation, ␤ 3 phosphorylation was observed only in Src ϩϩ and SYFϩ c-Src cells, not in SYF-cells (supplemental Figure IXA) . Thus, c-Src controls . c-Src directly phosphorylates ␤ 3 integrin at cytoplasmic tyrosine motifs. A, HUVECs were detached and either kept in suspension or adhered in the presence of SU6656 (400 nmol/L) to vitronectin-coated plates. HUVECs were also transfected with WT Src, DN-Src, or CA-Src and were then induced with 20 ng/mL VEGF for 5 minutes. Cell lysates were resolved by SDS-PAGE and analyzed for phosphorylation of ␤ 3 using specific antibodies. B, Src ϩϩ , SYF, and SYF ϩ Src cells were either kept in suspension or plated on an uncoated plastic surface or on vitronectin-, laminin-, or collagen-coated surfaces and allowed to adhere and spread for 30 minutes. HUVECs plated on vitronectin-coated surface were used as a positive control (lane 1). Cell lysates were analyzed for phosphorylation of ␤ 3 using specific antibody (B). C and D, Kinase assays were performed using recombinant ␤ 3 cytoplasmic tail-glutathione S-transferase (GST) fusion protein (C). Kinase assays were also performed in the presence of c-Src inhibitor SU6656 (400 nmol/L) and recombinant protein tyrosine phosphatase (PTP) to ensure phosphorylation is tyrosine specific. Peptides derived from distinct cytoplasmic regions of ␤ 3 were also used as substrates for kinase assays under similar conditions (D). cell adhesion as well as growth factor-induced ␤ 3 tyrosine phosphorylation.
c-Src Directly Phosphorylates Cytoplasmic Tyrosine Motifs of ␤ 3 Integrin
To examine whether c-Src can directly mediate ␤ 3 tyrosine phosphorylation, c-Src was immunoprecipitated from VEGFstimulated HUVECs. Immunocomplexes were incubated with purified full-length ␤ 3 cytoplasmic domain, and [␥-32 P] ATP incorporation was monitored. As shown in Figure 3C , the immunoprecipitated c-Src can phosphorylate ␤ 3 cytoplasmic domain (lane 2). The inhibitor SU6656 blocked this process, confirming the specificity of the reaction (lane 3). Recombinant protein tyrosine phosphatase also prevented phosphorylation, indicating that it is a tyrosine substrate that is being phosphorylated (lane 4). Recombinant purified c-Src also phosphorylated ␤ 3 whereas none was observed without the substrate, demonstrating specificity (lanes 1 and 5). Together, these results clearly show that c-Src can directly phosphorylate ␤ 3 cytoplasmic tyrosines.
To further investigate phosphorylation of Tyr747 and/or Tyr759, kinase assays were performed using as substrate peptides derived from these 2 distinct ␤ 3 sites ( Figure 3D ). SU6656, which blocks c-Src autophosphorylation, was used to demonstrate specificity. In the absence of integrin substrate, a significant amount of c-Src autophosphorylation was observed, indicating that the immunoprecipitated c-Src complex is active. In the presence of Tyr747/Tyr759 ␤ 3 cytoplasmic peptide, a dramatic increase in [␥-32 P] ATP incorporation was observed compared with control peptides devoid of tyrosine motifs. Similar results were observed using purified recombinant c-Src protein. As anticipated, [␥-32 P] ATP incorporation was minimal in the presence of purified recombinant protein tyrosine phosphatase, demonstrating the role of c-Src in phosphorylation of tyrosine residues. Together, these results clearly indicate that c-Src directly phosphorylates both tyrosine motifs (Tyr747 and Tyr759) of the cytoplasmic tail of ␤ 3 . Furthermore, VEGF-stimulated Akt phosphorylation was maximum in HUVECs grown on vitronectin compared with other integrin ligands (supplemental Figure VIA and VIB). However, the phosphatidylinositol 3-kinase/Akt pathway was not involved in VEGF-induced ␤ 3 tyrosine phosphorylation (supplemental Figure VIC) .
c-Src-Mediated ␤ 3 Integrin Tyrosine Phosphorylation Is Critical for VEGF-Induced VEGFR-2-␤ 3 Integrin Macromolecular Complex Formation
Our previous results indicate that VEGF-induced VEGFR-2 tyrosine phosphorylation was maximal in cells plated on only ␣ v ␤ 3 ligand vitronectin and that VEGFR-2 shows maximum interaction with ␤ 3 in ECs. Therefore, we sought to examine the role of Src-mediated ␤ 3 phosphorylation in ␤ 3 interaction with VEGFR-2. Accordingly, c-Src activity was modified by overexpression of WT, DN, or CA forms of Src or by treatment of cells with Src and VEGFR-2 inhibitors; interaction between VEGFR-2 and ␤ 3 was then assessed. In unstimulated cells, no interaction between ␤ 3 and VEGFR-2 was observed ( Figure 4A and 4B, lane 1) , whereas VEGF induced strong interaction between VEGFR-2 and ␤ 3 (lane 2). Treatment of cells with pharmacological inhibitors of c-Src and VEGFR-2 known to inhibit ␤ 3 phosphorylation prevented VEGF-stimulated interaction between ␤ 3 and VEGFR-2 (lanes 3 and 4) . Likewise, transfection with DN-Src reduced, whereas CA-Src enhanced, interaction between the 2 receptors ( lanes 6 and 7) . Furthermore, c-Src also partially regulated VEGFR-2 phosphorylation in ECs (supplemental Figure  VIIA) . These results indicate that the c-Src-mediated phosphorylation of ␤ 3 integrin essentially regulates interaction between ␤ 3 integrin and VEGFR-2 in ECs.
To further analyze the roles of ␤ 3 cytoplasmic tyrosine motifs in ␤ 3 integrin/VEGFR-2 interaction, we used lung ECs derived from ␤ 3 knock-in mice in which Tyr747 and Tyr759 were mutated to phenylalanine (DiYF). Supplemental Figure  IIC shows that VEGF induced phosphorylation of ␤ 3 at Tyr747 and Tyr759 in WT but not in DiYF EC. To further assess the role of c-Src-mediated ␤ 3 phosphorylation, WT and DiYF ECs were transfected with DN or CA forms of Src and then interactions between VEGFR-2 and ␤ 3 were examined. VEGF-induced interaction between ␤ 3 and VEGFR-2 was observed only in WT cells ( Figure 4C, lane 3) , whereas in unstimulated cells, no interaction was found (lane 2). Transfection with DN-Src diminished, whereas CA-Src enhanced, the interaction between ␤ 3 and VEGFR-2 only in WT cells (lanes 4 and 5). Transfection with CA-Src also enhanced the interaction between VEGFR-2 and ␤ 3 in the absence of VEGF (supplemental Figure VIIIA) . Under all of these conditions, no interactions were found between ␤ 3 integrin and VEGFR-2 in DiYF cells. These results clearly demonstrate that c-Src-mediated tyrosine phosphorylation of ␤ 3 integrin controls VEGF-induced ␤ 3 integrin and VEGFR-2 interaction in ECs.
c-Src Is Critical for Growth Factor-Induced ␤ 3 Integrin Activation and Ligand Binding
An intrinsic property of integrins is an increase in soluble ligand binding in response to stimulation, a process called integrin activation. Our results indicate that c-Src directly phosphorylates ␤ 3 on cytoplasmic tyrosines, which might affect integrin functional activity. To address this issue, HUVECs were transfected with WT, DN, and CA forms of c-Src and then stimulated with VEGF. Subsequently, ␣ v ␤ 3 activation was assessed by WOW-1 binding as described under Materials and Methods. As anticipated, VEGF induced a 6-fold increase in WOW-1 binding ( Figure 4D ). DN-Src reduced ␣ v ␤ 3 activation triggered by VEGF by at least 2-fold. In contrast, CA-Src promoted WOW-1 binding to unstimulated as well as to VEGF-stimulated cells ( Figure 4D) . Similar results were observed using fibrinogen as a soluble ligand for ␣ v ␤ 3 ( Figure 4E ). Furthermore, activation and ligand binding were also assessed using Src ϩϩ , SYF, and SYF ϩ Src cells. Basic fibroblast growth factor stimulation resulted in a dramatic increase in integrin activation in Src ϩϩ and SYF ϩ Src but not in SYF cells, as measured by WOW-1 or fibrinogen binding (supplemental Figure IXB and IXD) . No differences in ␤ 3 expression levels were found between these 3 cell lines (supplemental Figure IXC) . Thus, c-Src and c-Src-dependent ␤ 3 cytoplasmic tyrosine phosphorylation are essential for VEGF-induced ␣ v ␤ 3 activation and ligand binding to activated integrin, both crucial steps in integrin signaling.
c-Src Is Required for ␣ v ␤ 3 Integrin-Dependent Cellular Adhesion to Distinct Ligand
To examine the role of c-Src in ␣ v ␤ 3 -dependent cell adhesion to ECM ligands, we used Src ϩϩ , SYF, and SYF ϩ Src cell systems. Src ϩϩ and SYF ϩ Src cells displayed the highest levels of adhesion to vitronectin, which is primarily recognized by ␣ v ␤ 3 . SYF cells showed at least 3-fold lower adhesion on vitronectin compared with Src ϩϩ or SYF ϩ Src cells ( Figure 5A and 5B ), although no differences in cell adhesion to collagen or laminin were observed. Adhesion of HUVECs on vitronectin was assessed on expression of WT, DN, and CA forms of Src or on treatment with inhibitor SU6656 (Figure 5C ). CA-Src promoted ␣ v ␤ 3 -dependent cell adhesion, whereas DN-Src and Src inhibitor caused impairment of adhesion to vitronectin. These results indicate that c-Src plays a crucial role in ␣ v ␤ 3 -dependent cell adhesion to ECM ligands.
Our results also indicated that Src phosphorylates ␤ 3 on cytoplasmic tyrosines, which may be required for ␣ v ␤ 3dependent ECM reorganization. To evaluate this, WT and DiYF mouse lung microvascular ECs were incubated on vitronectin or bone sialoprotein, ␣ v ␤ 3 -specific ligands. DiYF ECs showed significantly impaired adhesion to vitronectin as well as bone sialoprotein ( Figure 5D ). No significant differences in adhesion were found between WT and DiYF ECs incubated on BSA-coated plates. These results clearly show that ␤ 3 cytoplasmic tyrosines and c-Src-mediated phosphorylation of these residues are essential for ␣ v ␤ 3 -dependent cellular adhesion to distinct ECM ligands.
␤ 3 Integrin Cytoplasmic Tyrosines Are Required for Directional Migration of Endothelial Cells
EC motility is the defining feature of angiogenesis, required for the organization of proliferating ECs into vessel-like structures. To assess the role of Src-mediated ␤ 3 tyrosine phosphorylation in ␣ v ␤ 3 -dependent EC migration, HUVECs transfected with various forms (DN and CA) of Src were evaluated in migration assays using VEGF as an agonist and vitronectin as a substrate. DN-Src significantly reduced EC migration in response to VEGF, whereas CA-Src dramatically increased both basal and VEGF-induced EC migration ( Figure 6A ). Pharmacological inhibitors of c-Src and VEGFR-2 also reduced EC migration triggered by VEGF (supplemental Figure  VIIIB) . To further evaluate the c-Src-mediated ␤ 3 phosphorylation in ␣ v ␤ 3 -dependent EC migration, WT and DiYF mouse lung microvascular ECs were transfected with WT, DN, and CA forms of c-Src and stimulated with VEGF ( Figure 6B ). VEGF stimulation induced increases in WT EC migration by 2.5-fold in WT-Src and 3.5-fold in CA-Src cells. DN-Src significantly tempered the VEGFinduced increase in migration in only WT ECs. Surprisingly, c-Src activity modulation did not result in any significant differences in migration of DiYF ECs. These results clearly indicate that c-Src mediates signaling through tyrosine phosphorylation of ␤ 3 integrin. Lack of these tyrosine residues in the cytoplasmic domain of ␤ 3 severely impaired c-Src-mediated ␣ v ␤ 3 integrin-dependent EC migration.
To examine the role of ␤ 3 cytoplasmic tyrosine motifs in directional migration of ECs, WT and DiYF ECs were cultured on collagen-, laminin-, or vitronectin-coated plates. Wounds were created, and VEGF-A 165 -stimulated cell migration was monitored by time-lapse video microscopy. Cell paths were recorded and are presented in Figure 6C . WT and DiYF ECs plated on laminin exhibited similar migration speeds, 53.2Ϯ4.8 and 47.2Ϯ4.2 m/h, respectively. On collagen, WT and DiYF ECs also showed similar migration rates, of 43.2Ϯ3.5 and 44.5Ϯ3.3 m/h, respectively. On vitronectin, WT and DiYF ECs showed relatively slow but similar migration at 30.8Ϯ3.2 and 28.3Ϯ2.7 m/h, respectively. However, when random movement was distinguished from directed migration, the results became quite different. Despite the high speed of migration, the average distance of directed migration from site of origin was relatively low for WT cells on laminin and collagen, 71Ϯ6.2 and 92Ϯ7.2 m respectively ( Figure 6C ). No differences between WT and DiYF cells were found. In contrast, WT ECs showed maximum directed migration when plated on vitronectin (229Ϯ6.6 m). Importantly, directed migration by DiYF cells was dramatically impaired (77Ϯ5.4 m versus 229Ϯ6.6 m for WT). WT ECs plated on ␣ v ␤ 3 ligand vitronectin following induction with VEGF-A 165 resulted in higher directional persistence of cell migration (supplemental Figure IVA) . Simultaneously, DiYF ECs plated on vitronectin and induced with VEGF showed random movement with no distinct pattern. Furthermore, ECs stimulated with VEGF grown on vitronectin also exhibited greater rates of proliferation without significant differences in rates of apoptosis (supplemental Figures IIIA, IIIB, IVB, VA, VB) . These results clearly demonstrate that ␤ 3 integrin cytoplasmic tyrosine motifs are required for persistent and directional migration of ECs during the process of angiogenesis.
␤ 3 Integrin Cytoplasmic Tyrosine Phosphorylation Is Crucial for Organization of the Angiogenic Program in Endothelial Cells
To further evaluate the functional significance of c-Srcdependent ␤ 3 phosphorylation, the ability of ECs to organize into precapillary tube-like structures was tested. Accordingly, WT and DiYF mouse microvascular ECs were transfected with the various activation forms of Src. These cells were seeded on Matrigel-coated plates and allowed to organize into precapillary tube-like structures. Overexpression of DN-Src significantly reduced, whereas the CA form of Src dramatically enhanced, VEGF-induced tube formation on Matrigel in only WT cells ( Figure 6D and 6E) . Both VEGF and the varied forms of Src failed to modify the degree of tube formation in DiYF ECs. From all of these results, we conclude that c-Src-dependent ␤ 3 integrin cytoplasmic tyrosine phosphorylation is essential for ␣ v ␤ 3 -dependent EC migration as well as precapillary endothelial tube formation on extracellular matrix substrates. Thus, ␤ 3 cytoplasmic tyrosine motifs are crucial for initiation of the angiogenic program in ECs and ultimately regulate the processes of angiogenesis.
Discussion
This study focused on the mechanisms and molecular requirements for the crosstalk and cross-activation between 2 families of cell surface receptors on endothelium: integrins, receptors for extracellular matrix, and tyrosine kinase receptors, represented by VEGFR-2. The major findings in this manuscript are: (1) there is an intimate and coordinated relationship between VEGFR-2 and ␣ v ␤ 3 integrin; (2) adhesion-and growth factor-induced ␤ 3 integrin tyrosine phosphorylation is directly mediated by c-Src; (3) c-Srcdependent ␤ 3 integrin tyrosine phosphorylation is critical for interaction between VEGFR-2 and ␤ 3 integrin; and 4) c-Src is required for growth factor-induced ␤ 3 integrin activation, ligand binding, and ␣ v ␤ 3 integrin-dependent cellular adhesion. We have demonstrated that VEGF induces association of its receptor VEGFR-2 with the ␤ 3 subunit of ␣ v ␤ 3 , but not with ␤ 1 or ␤ 5 integrins, on ECs. Blocking antibodies against either the ␣ v or ␤ 3 subunits independently blocked VEGF-induced phosphorylation of ␤ 3 cytoplasmic tyrosines and VEGF-induced VEGFR-2 phosphorylation. We found that phosphorylation of tyrosine within the ␤ 3 cytoplasmic domain occurred in response to VEGF and, in turn, was essential for VEGFR-2-␤ 3 integrin association and VEGFR-2 activation and subsequent signaling. Thus, crosstalk between the 2 receptors determines the cellular responses to VEGF as well as to integrin ligation, which, in turn, is regulated by tyrosine phosphorylation events.
We have identified c-Src as a molecule that directly phosphorylates the cytoplasmic tyrosines of ␤ 3 in response to VEGF stimulation, enabling it to directly control VEGFinduced and integrin-mediated cellular responses such as cell adhesion and migration. Src, Yes, and Fyn triple mutant cells (SYF) exhibited severely impaired ␤ 3 tyrosine phosphorylation in response to growth factors, which was corrected by reexpression of c-Src alone. Potentially, kinases other than c-Src may also contribute to VEGF-induced ␤ 3 phosphorylation in other cell lines. In ECs, Src, but neither Yes nor Fyn, was able to interact with VEGFR-2 and ␤ 3 in a VEGFdependent manner. Recent observations have demonstrated that Src is required for VEGF-induced vascular permeability, a response triggered by VEGFR-2 activation. 23 Moreover, c-Src is able to modulate blood vessel development in several experimental animal models. 24 Here we have demonstrated that growth factor-stimulated ligand binding to ␣ v ␤ 3 on ECs is c-Src dependent. In triple knockout cells (SYF), the lack of Src activity resulted in deficient ␤ 3 phosphorylation, which, in turn, led to severe impairment in growth factor-induced ligand binding, a prerequisite for growth factor-modulated cell adhesion, spreading, and migration. Thus, we conclude that c-Src is crucial for integrin activation in response to growth factors and have also demonstrated the intimate association of Src and integrin signaling. 25 In fact, several features of the Src knockout phenotype, including osteopetrosis, show a close resemblance to the phenotype of ␤ 3 -null mice. 26 The presence of the ␤ 3 /Src complex at the leading edges of adherent cells further demonstrates their intimate association in basic cellular processes. 27 Furthermore, mouse embryonic fibroblasts containing c-Src (Src ϩϩ and SYF ϩ Src) showed a greater tendency to adhere to vitronectin-coated surfaces than to collagen-or laminin-coated surfaces. These results strengthen our conclusion that c-Src is required mainly for vitronectin receptor signaling (␣ v ␤ 3 ) rather than collagen or laminin receptor signaling. Interestingly, only Src, not Fyn knockout, mice display impairment of VEGF-induced vascular responses and tumor burden, indicating that Src is the main SFK in the regulation of EC functions. 28 Our study also demonstrates that c-Src-dependent ␤ 3 cytoplasmic tyrosine phosphorylation is essential for ␣ v ␤ 3 integrin-dependent EC migration as well as precapillary endothelial tube formation on ECM substrates. Thus c-Src, via direct phosphorylation of ␤ 3 integrin cytoplasmic tyrosines, controls the functional association between ␣ v ␤ 3 and VEGFR-2, which, in turn, regulates activation of both receptors on ECs. This functional interplay is crucial for EC adhesion, migration, and initiation of angiogenic programming in ECs.
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